Moderna and Pfizer urged to share vaccine technology with developing world

Pressure is mounting on Moderna and Pfizer to share vaccine technology with the developing world after the two biggest proxy advisers lent support to shareholder resolutions. Institutional Shareholder Services has recommended that investors vote in favour of proposals by Oxfam America that would compel Moderna and Pfizer to commission third-party reports about transferring their vaccine technology. The drive to expand access to the well-performing mRNA vaccines comes as Moderna unveiled strong trial results for a new “bivalent” vaccine. Oxfam is lobbying to create a more equal distribution of Covid-19 vaccines, arguing that not sharing the IP and technical knowhow creates reputational risks and could slow the end of the pandemic.